The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kruse Bo since 2020.
This trader's CIK number is 1752940.
At the time of last reporting, Kruse Bo was the EVP, CFO, SECRY & TREAS. of Y-mabs Therapeutics, Inc.. (stock ticker symbol YMAB).
Also see all insider trading activities at Y-mabs Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | YMAB | 0 | $0 | 60,000 | $723,053 | 60,000 | $120,000 |
| 2022 | YMAB | 0 | $0 | 12,000 | $139,720 | 0 | $0 |
| 2021 | YMAB | 0 | $0 | 56,000 | $1,586,120 | 0 | $0 |
| 2020 | YMAB | 0 | $0 | 100,000 | $3,665,244 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-30 | YMAB | Option Ex | 28,629 | 2.00 | 57,258 |
| 2024-05-31 | YMAB | Option Ex | 31,371 | 2.00 | 62,742 |
| 2024-05-30 | YMAB | Sale | 28,629 | 12.03 | 344,406 |
| 2024-05-31 | YMAB | Sale | 31,371 | 12.07 | 378,647 |
| 2022-02-04 | YMAB | Sale | 4,000 | 7.97 | 31,880 |
| 2022-01-24 | YMAB | Sale | 4,000 | 9.84 | 39,360 |
| 2022-01-04 | YMAB | Sale | 4,000 | 17.12 | 68,480 |
| 2021-12-22 | YMAB | Sale | 4,000 | 16.36 | 65,440 |
| 2021-12-06 | YMAB | Sale | 4,000 | 16.35 | 65,400 |
| 2021-11-22 | YMAB | Sale | 4,000 | 18.09 | 72,360 |
| 2021-11-04 | YMAB | Sale | 4,000 | 27.54 | 110,160 |
| 2021-10-22 | YMAB | Sale | 4,000 | 25.94 | 103,760 |
| 2021-10-04 | YMAB | Sale | 4,000 | 28.78 | 115,120 |
| 2021-09-22 | YMAB | Sale | 4,000 | 30.82 | 123,280 |
| 2021-09-07 | YMAB | Sale | 4,000 | 32.03 | 128,120 |
| 2021-08-23 | YMAB | Sale | 4,000 | 28.60 | 114,400 |
| 2021-08-04 | YMAB | Sale | 4,000 | 33.72 | 134,880 |
| 2021-07-22 | YMAB | Sale | 4,000 | 34.50 | 138,000 |
| 2021-07-06 | YMAB | Sale | 4,000 | 34.15 | 136,600 |
| 2021-06-22 | YMAB | Sale | 4,000 | 36.17 | 144,680 |
| 2021-06-04 | YMAB | Sale | 4,000 | 33.48 | 133,920 |
| 2020-05-13 | YMAB | Sale | 33,954 | 37.87 | 1,285,871 |
| 2020-05-14 | YMAB | Sale | 66,046 | 36.03 | 2,379,373 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kruse Bo (EVP, CFO, SECRY & TREAS. of Y-mabs Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.